Manufacturing and Quality Assurance
Manufacturing and Quality Assurance
JCR contributes to healthcare through the manufacture and supply of recombinant biopharmaceuticals, regenerative medicine products, and pharmaceutical raw materials. With an integrated framework spanning research and development through manufacturing and commercialization, JCR ensures the stable supply of high-quality medicines by leveraging advanced biotechnology and state-of-the-art production systems to meet evolving market needs.
Stable Global Supply for Commercial and Investigational Products
JCR operates a unified quality system across its manufacturing sites, covering the entire product lifecycle from early research through clinical and commercial production. By fostering a quality-driven culture and developing skilled personnel, JCR consistently delivers high-quality biopharmaceuticals.
Through secure sourcing of raw materials, appropriate inventory management, and flexible production scheduling, JCR maintains a stable global supply chain for its products, including investigational medicines.
An Integrated Manufacturing and Research Structure
JCR operates five manufacturing sites in Nishi-ku, Kobe, producing pharmaceuticals and regenerative medicine products under strict quality controls in compliance with GMP, GCTP, and applicable regulations.
By consolidating research facilities in the same area, JCR fosters close cross-functional collaboration from early research through commercial production, enabling efficient and consistent manufacturing. Grounded in decades of expertise in biopharmaceutical production, this integrated structure reflects a strong manufacturing culture and supports a resilient supply system capable of responding to emergencies, including pandemics.
Global Manufacturing Capacity and Operational Flexibility
At the formulation plant currently under construction within the Kobe Science Park Center, JCR will manufacture biopharmaceuticals under normal operations. In times of emergency, the facility will work in coordination with the adjacent active pharmaceutical ingredient (API) plant to support contract manufacturing of vaccines and other products.
Through this initiative, JCR is strengthening its production infrastructure to meet internationally recognized quality standards and support further global expansion.